Scientists have identified new ways lithium chloride may interact with Alzheimer’s disease mechanisms at the cellular level.
Researchers suggest targeting mTOR activity in aggressive cancers by blocking cholesterol sensing may represent a promising ...
Kinases that shuttle cholesterol within tumor cells help fuel growth. Blocking these enzymes may starve cancer cells, ...
While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for ...
While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for the metabolite. Some tumor ...
Zacks Investment Research on MSN
EXEL collaborates with MRK for late-stage colorectal cancer study
Exelixis EXEL announced a clinical development collaboration with pharma giant Merck & Co. MRK to evaluate its pipeline candidate, zanzalintinib, in combination with subcutaneous Keytruda Qlex in the ...
Researchers at the Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, together with collaborators from RIKEN Center for Sustainable Resource Science (RIKEN CSRS) and The ...
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious ...
A study revealed that lithium chloride altered several newly identified Alzheimer’s-relevant Tau phosphosites and may ...
Rare cancer expert Taran Gujral, PhD, cares more about what a cancer drug can do than what it is designed to do. His lab at Fred Hutch Cancer Center investigates a promising target for cancer drugs — ...
MKIs uniquely block multiple receptor tyrosine kinases (RTKs) simultaneously, addressing the inflammatory, vascular, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results